Recent data indicates that retatrutide, a dual-action medication, may represent a major improvement in size reduction . This drug combines the actions of a GLP-1 analog and a GIP receptor , possibly offering a enhanced impact than available approaches read more . Clinical research have shown positive results , including significant reductions in we